In this study, we demonstrated that despite high PKM2 expression in patients with UC or CRC and its correlation with poor clinical outcomes in patient-derived genomic data, development of inflammation-induced CRC was accelerated in mice with the deletion of PKM2 in Lgr5+ ISC or in intestinal epithelial cells. The gene discussed is LGR5; the disease is colorectal carcinoma.